We've found
9,220
archived clinical trials in
HIV / AIDS
We've found
9,220
archived clinical trials in
HIV / AIDS
Elvucitabine/Efavirenz/Tenofovir vs. Lamivudine/Efavirenz/Tenofovir in HIV-1 Infected, Treatment Naive Subjects
Updated: 2/22/2016
A Randomized, Blinded, 12-week Comparison of Elvucitabine/Efavirenz/Tenofovir Versus Lamivudine/Efavirenz/Tenofovir in HIV-1 Infected, Treatment Naive Subjects. There is a 36 Week, Open Label, Extension Phase for Eligible Subjects.
Status: Enrolling
Updated: 2/22/2016
Elvucitabine/Efavirenz/Tenofovir vs. Lamivudine/Efavirenz/Tenofovir in HIV-1 Infected, Treatment Naive Subjects
Updated: 2/22/2016
A Randomized, Blinded, 12-week Comparison of Elvucitabine/Efavirenz/Tenofovir Versus Lamivudine/Efavirenz/Tenofovir in HIV-1 Infected, Treatment Naive Subjects. There is a 36 Week, Open Label, Extension Phase for Eligible Subjects.
Status: Enrolling
Updated: 2/22/2016
Click here to add this to my saved trials
Elvucitabine/Efavirenz/Tenofovir vs. Lamivudine/Efavirenz/Tenofovir in HIV-1 Infected, Treatment Naive Subjects
Updated: 2/22/2016
A Randomized, Blinded, 12-week Comparison of Elvucitabine/Efavirenz/Tenofovir Versus Lamivudine/Efavirenz/Tenofovir in HIV-1 Infected, Treatment Naive Subjects. There is a 36 Week, Open Label, Extension Phase for Eligible Subjects.
Status: Enrolling
Updated: 2/22/2016
Elvucitabine/Efavirenz/Tenofovir vs. Lamivudine/Efavirenz/Tenofovir in HIV-1 Infected, Treatment Naive Subjects
Updated: 2/22/2016
A Randomized, Blinded, 12-week Comparison of Elvucitabine/Efavirenz/Tenofovir Versus Lamivudine/Efavirenz/Tenofovir in HIV-1 Infected, Treatment Naive Subjects. There is a 36 Week, Open Label, Extension Phase for Eligible Subjects.
Status: Enrolling
Updated: 2/22/2016
Click here to add this to my saved trials
Elvucitabine/Efavirenz/Tenofovir vs. Lamivudine/Efavirenz/Tenofovir in HIV-1 Infected, Treatment Naive Subjects
Updated: 2/22/2016
A Randomized, Blinded, 12-week Comparison of Elvucitabine/Efavirenz/Tenofovir Versus Lamivudine/Efavirenz/Tenofovir in HIV-1 Infected, Treatment Naive Subjects. There is a 36 Week, Open Label, Extension Phase for Eligible Subjects.
Status: Enrolling
Updated: 2/22/2016
Elvucitabine/Efavirenz/Tenofovir vs. Lamivudine/Efavirenz/Tenofovir in HIV-1 Infected, Treatment Naive Subjects
Updated: 2/22/2016
A Randomized, Blinded, 12-week Comparison of Elvucitabine/Efavirenz/Tenofovir Versus Lamivudine/Efavirenz/Tenofovir in HIV-1 Infected, Treatment Naive Subjects. There is a 36 Week, Open Label, Extension Phase for Eligible Subjects.
Status: Enrolling
Updated: 2/22/2016
Click here to add this to my saved trials
Estimating the Global Need for Palliative Care for Children
Updated: 2/22/2016
Estimating the Global Need for Palliative Care for Children: A Cross Sectional Analysis
Status: Enrolling
Updated: 2/22/2016
Estimating the Global Need for Palliative Care for Children
Updated: 2/22/2016
Estimating the Global Need for Palliative Care for Children: A Cross Sectional Analysis
Status: Enrolling
Updated: 2/22/2016
Click here to add this to my saved trials
Centralized Off-Site Adherence Enhancement Program
Updated: 2/23/2016
Centralized Off-Site Adherence Enhancement Program
Status: Enrolling
Updated: 2/23/2016
Centralized Off-Site Adherence Enhancement Program
Updated: 2/23/2016
Centralized Off-Site Adherence Enhancement Program
Status: Enrolling
Updated: 2/23/2016
Click here to add this to my saved trials
Diet, Exercise, Niacin, and Fenofibrate to Reduce Heart Disease Risk Factors in Individuals With HIV Lipodystrophy or Dyslipidemia
Updated: 2/25/2016
Diet/Exercise, Niacin, Fenofibrate for HIV Lipodystrophy
Status: Enrolling
Updated: 2/25/2016
Diet, Exercise, Niacin, and Fenofibrate to Reduce Heart Disease Risk Factors in Individuals With HIV Lipodystrophy or Dyslipidemia
Updated: 2/25/2016
Diet/Exercise, Niacin, Fenofibrate for HIV Lipodystrophy
Status: Enrolling
Updated: 2/25/2016
Click here to add this to my saved trials
Smoking Cessation for HIV/AIDS Patients
Updated: 2/25/2016
An Innovative Telephone Intervention for HIV-Positive Smokers
Status: Enrolling
Updated: 2/25/2016
Smoking Cessation for HIV/AIDS Patients
Updated: 2/25/2016
An Innovative Telephone Intervention for HIV-Positive Smokers
Status: Enrolling
Updated: 2/25/2016
Click here to add this to my saved trials
Smoking Cessation for HIV/AIDS Patients
Updated: 2/25/2016
An Innovative Telephone Intervention for HIV-Positive Smokers
Status: Enrolling
Updated: 2/25/2016
Smoking Cessation for HIV/AIDS Patients
Updated: 2/25/2016
An Innovative Telephone Intervention for HIV-Positive Smokers
Status: Enrolling
Updated: 2/25/2016
Click here to add this to my saved trials
Motivational Enhancement System for Adherence
Updated: 2/29/2016
Computer-Delivered Motivational Intervention to Prevent Adherence Problems Among Youth Newly Recommended for HIV Medications: Project MESA (Motivational Enhancement System for Adherence)
Status: Enrolling
Updated: 2/29/2016
Motivational Enhancement System for Adherence
Updated: 2/29/2016
Computer-Delivered Motivational Intervention to Prevent Adherence Problems Among Youth Newly Recommended for HIV Medications: Project MESA (Motivational Enhancement System for Adherence)
Status: Enrolling
Updated: 2/29/2016
Click here to add this to my saved trials
Motivational Enhancement System for Adherence
Updated: 2/29/2016
Computer-Delivered Motivational Intervention to Prevent Adherence Problems Among Youth Newly Recommended for HIV Medications: Project MESA (Motivational Enhancement System for Adherence)
Status: Enrolling
Updated: 2/29/2016
Motivational Enhancement System for Adherence
Updated: 2/29/2016
Computer-Delivered Motivational Intervention to Prevent Adherence Problems Among Youth Newly Recommended for HIV Medications: Project MESA (Motivational Enhancement System for Adherence)
Status: Enrolling
Updated: 2/29/2016
Click here to add this to my saved trials
Motivational Enhancement System for Adherence
Updated: 2/29/2016
Computer-Delivered Motivational Intervention to Prevent Adherence Problems Among Youth Newly Recommended for HIV Medications: Project MESA (Motivational Enhancement System for Adherence)
Status: Enrolling
Updated: 2/29/2016
Motivational Enhancement System for Adherence
Updated: 2/29/2016
Computer-Delivered Motivational Intervention to Prevent Adherence Problems Among Youth Newly Recommended for HIV Medications: Project MESA (Motivational Enhancement System for Adherence)
Status: Enrolling
Updated: 2/29/2016
Click here to add this to my saved trials
Motivational Enhancement System for Adherence
Updated: 2/29/2016
Computer-Delivered Motivational Intervention to Prevent Adherence Problems Among Youth Newly Recommended for HIV Medications: Project MESA (Motivational Enhancement System for Adherence)
Status: Enrolling
Updated: 2/29/2016
Motivational Enhancement System for Adherence
Updated: 2/29/2016
Computer-Delivered Motivational Intervention to Prevent Adherence Problems Among Youth Newly Recommended for HIV Medications: Project MESA (Motivational Enhancement System for Adherence)
Status: Enrolling
Updated: 2/29/2016
Click here to add this to my saved trials
Motivational Enhancement System for Adherence
Updated: 2/29/2016
Computer-Delivered Motivational Intervention to Prevent Adherence Problems Among Youth Newly Recommended for HIV Medications: Project MESA (Motivational Enhancement System for Adherence)
Status: Enrolling
Updated: 2/29/2016
Motivational Enhancement System for Adherence
Updated: 2/29/2016
Computer-Delivered Motivational Intervention to Prevent Adherence Problems Among Youth Newly Recommended for HIV Medications: Project MESA (Motivational Enhancement System for Adherence)
Status: Enrolling
Updated: 2/29/2016
Click here to add this to my saved trials
Motivational Enhancement System for Adherence
Updated: 2/29/2016
Computer-Delivered Motivational Intervention to Prevent Adherence Problems Among Youth Newly Recommended for HIV Medications: Project MESA (Motivational Enhancement System for Adherence)
Status: Enrolling
Updated: 2/29/2016
Motivational Enhancement System for Adherence
Updated: 2/29/2016
Computer-Delivered Motivational Intervention to Prevent Adherence Problems Among Youth Newly Recommended for HIV Medications: Project MESA (Motivational Enhancement System for Adherence)
Status: Enrolling
Updated: 2/29/2016
Click here to add this to my saved trials
Motivational Enhancement System for Adherence
Updated: 2/29/2016
Computer-Delivered Motivational Intervention to Prevent Adherence Problems Among Youth Newly Recommended for HIV Medications: Project MESA (Motivational Enhancement System for Adherence)
Status: Enrolling
Updated: 2/29/2016
Motivational Enhancement System for Adherence
Updated: 2/29/2016
Computer-Delivered Motivational Intervention to Prevent Adherence Problems Among Youth Newly Recommended for HIV Medications: Project MESA (Motivational Enhancement System for Adherence)
Status: Enrolling
Updated: 2/29/2016
Click here to add this to my saved trials
Motivational Enhancement System for Adherence
Updated: 2/29/2016
Computer-Delivered Motivational Intervention to Prevent Adherence Problems Among Youth Newly Recommended for HIV Medications: Project MESA (Motivational Enhancement System for Adherence)
Status: Enrolling
Updated: 2/29/2016
Motivational Enhancement System for Adherence
Updated: 2/29/2016
Computer-Delivered Motivational Intervention to Prevent Adherence Problems Among Youth Newly Recommended for HIV Medications: Project MESA (Motivational Enhancement System for Adherence)
Status: Enrolling
Updated: 2/29/2016
Click here to add this to my saved trials
Motivational Enhancement System for Adherence
Updated: 2/29/2016
Computer-Delivered Motivational Intervention to Prevent Adherence Problems Among Youth Newly Recommended for HIV Medications: Project MESA (Motivational Enhancement System for Adherence)
Status: Enrolling
Updated: 2/29/2016
Motivational Enhancement System for Adherence
Updated: 2/29/2016
Computer-Delivered Motivational Intervention to Prevent Adherence Problems Among Youth Newly Recommended for HIV Medications: Project MESA (Motivational Enhancement System for Adherence)
Status: Enrolling
Updated: 2/29/2016
Click here to add this to my saved trials
Motivational Enhancement System for Adherence
Updated: 2/29/2016
Computer-Delivered Motivational Intervention to Prevent Adherence Problems Among Youth Newly Recommended for HIV Medications: Project MESA (Motivational Enhancement System for Adherence)
Status: Enrolling
Updated: 2/29/2016
Motivational Enhancement System for Adherence
Updated: 2/29/2016
Computer-Delivered Motivational Intervention to Prevent Adherence Problems Among Youth Newly Recommended for HIV Medications: Project MESA (Motivational Enhancement System for Adherence)
Status: Enrolling
Updated: 2/29/2016
Click here to add this to my saved trials
Motivational Enhancement System for Adherence
Updated: 2/29/2016
Computer-Delivered Motivational Intervention to Prevent Adherence Problems Among Youth Newly Recommended for HIV Medications: Project MESA (Motivational Enhancement System for Adherence)
Status: Enrolling
Updated: 2/29/2016
Motivational Enhancement System for Adherence
Updated: 2/29/2016
Computer-Delivered Motivational Intervention to Prevent Adherence Problems Among Youth Newly Recommended for HIV Medications: Project MESA (Motivational Enhancement System for Adherence)
Status: Enrolling
Updated: 2/29/2016
Click here to add this to my saved trials
Motivational Enhancement System for Adherence
Updated: 2/29/2016
Computer-Delivered Motivational Intervention to Prevent Adherence Problems Among Youth Newly Recommended for HIV Medications: Project MESA (Motivational Enhancement System for Adherence)
Status: Enrolling
Updated: 2/29/2016
Motivational Enhancement System for Adherence
Updated: 2/29/2016
Computer-Delivered Motivational Intervention to Prevent Adherence Problems Among Youth Newly Recommended for HIV Medications: Project MESA (Motivational Enhancement System for Adherence)
Status: Enrolling
Updated: 2/29/2016
Click here to add this to my saved trials
Motivational Enhancement System for Adherence
Updated: 2/29/2016
Computer-Delivered Motivational Intervention to Prevent Adherence Problems Among Youth Newly Recommended for HIV Medications: Project MESA (Motivational Enhancement System for Adherence)
Status: Enrolling
Updated: 2/29/2016
Motivational Enhancement System for Adherence
Updated: 2/29/2016
Computer-Delivered Motivational Intervention to Prevent Adherence Problems Among Youth Newly Recommended for HIV Medications: Project MESA (Motivational Enhancement System for Adherence)
Status: Enrolling
Updated: 2/29/2016
Click here to add this to my saved trials
Motivational Enhancement System for Adherence
Updated: 2/29/2016
Computer-Delivered Motivational Intervention to Prevent Adherence Problems Among Youth Newly Recommended for HIV Medications: Project MESA (Motivational Enhancement System for Adherence)
Status: Enrolling
Updated: 2/29/2016
Motivational Enhancement System for Adherence
Updated: 2/29/2016
Computer-Delivered Motivational Intervention to Prevent Adherence Problems Among Youth Newly Recommended for HIV Medications: Project MESA (Motivational Enhancement System for Adherence)
Status: Enrolling
Updated: 2/29/2016
Click here to add this to my saved trials
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Updated: 2/29/2016
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Updated: 2/29/2016
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
Click here to add this to my saved trials
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Updated: 2/29/2016
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Updated: 2/29/2016
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
Click here to add this to my saved trials
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Updated: 2/29/2016
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Updated: 2/29/2016
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
Click here to add this to my saved trials
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Updated: 2/29/2016
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Updated: 2/29/2016
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
Click here to add this to my saved trials
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Updated: 2/29/2016
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Updated: 2/29/2016
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
Click here to add this to my saved trials
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Updated: 2/29/2016
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Updated: 2/29/2016
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
Click here to add this to my saved trials
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Updated: 2/29/2016
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Updated: 2/29/2016
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
Click here to add this to my saved trials
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Updated: 2/29/2016
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Updated: 2/29/2016
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
Click here to add this to my saved trials
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Updated: 2/29/2016
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Updated: 2/29/2016
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
Click here to add this to my saved trials
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Updated: 2/29/2016
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Updated: 2/29/2016
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
Click here to add this to my saved trials
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Updated: 2/29/2016
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Updated: 2/29/2016
Prevalence of Morphologic and Metabolic Abnormalities in HIV Infected and Uninfected Young Women
Status: Enrolling
Updated: 2/29/2016
Click here to add this to my saved trials
4-Day-A-Week Treatment Plan for HIV Infected Adolescents
Updated: 2/29/2016
Short-Cycle Therapy in Adolescents Following Continuous Therapy With Established Viral Suppression: The Impact on Viral Load Suppression
Status: Enrolling
Updated: 2/29/2016
4-Day-A-Week Treatment Plan for HIV Infected Adolescents
Updated: 2/29/2016
Short-Cycle Therapy in Adolescents Following Continuous Therapy With Established Viral Suppression: The Impact on Viral Load Suppression
Status: Enrolling
Updated: 2/29/2016
Click here to add this to my saved trials
4-Day-A-Week Treatment Plan for HIV Infected Adolescents
Updated: 2/29/2016
Short-Cycle Therapy in Adolescents Following Continuous Therapy With Established Viral Suppression: The Impact on Viral Load Suppression
Status: Enrolling
Updated: 2/29/2016
4-Day-A-Week Treatment Plan for HIV Infected Adolescents
Updated: 2/29/2016
Short-Cycle Therapy in Adolescents Following Continuous Therapy With Established Viral Suppression: The Impact on Viral Load Suppression
Status: Enrolling
Updated: 2/29/2016
Click here to add this to my saved trials
4-Day-A-Week Treatment Plan for HIV Infected Adolescents
Updated: 2/29/2016
Short-Cycle Therapy in Adolescents Following Continuous Therapy With Established Viral Suppression: The Impact on Viral Load Suppression
Status: Enrolling
Updated: 2/29/2016
4-Day-A-Week Treatment Plan for HIV Infected Adolescents
Updated: 2/29/2016
Short-Cycle Therapy in Adolescents Following Continuous Therapy With Established Viral Suppression: The Impact on Viral Load Suppression
Status: Enrolling
Updated: 2/29/2016
Click here to add this to my saved trials
4-Day-A-Week Treatment Plan for HIV Infected Adolescents
Updated: 2/29/2016
Short-Cycle Therapy in Adolescents Following Continuous Therapy With Established Viral Suppression: The Impact on Viral Load Suppression
Status: Enrolling
Updated: 2/29/2016
4-Day-A-Week Treatment Plan for HIV Infected Adolescents
Updated: 2/29/2016
Short-Cycle Therapy in Adolescents Following Continuous Therapy With Established Viral Suppression: The Impact on Viral Load Suppression
Status: Enrolling
Updated: 2/29/2016
Click here to add this to my saved trials
4-Day-A-Week Treatment Plan for HIV Infected Adolescents
Updated: 2/29/2016
Short-Cycle Therapy in Adolescents Following Continuous Therapy With Established Viral Suppression: The Impact on Viral Load Suppression
Status: Enrolling
Updated: 2/29/2016
4-Day-A-Week Treatment Plan for HIV Infected Adolescents
Updated: 2/29/2016
Short-Cycle Therapy in Adolescents Following Continuous Therapy With Established Viral Suppression: The Impact on Viral Load Suppression
Status: Enrolling
Updated: 2/29/2016
Click here to add this to my saved trials
4-Day-A-Week Treatment Plan for HIV Infected Adolescents
Updated: 2/29/2016
Short-Cycle Therapy in Adolescents Following Continuous Therapy With Established Viral Suppression: The Impact on Viral Load Suppression
Status: Enrolling
Updated: 2/29/2016
4-Day-A-Week Treatment Plan for HIV Infected Adolescents
Updated: 2/29/2016
Short-Cycle Therapy in Adolescents Following Continuous Therapy With Established Viral Suppression: The Impact on Viral Load Suppression
Status: Enrolling
Updated: 2/29/2016
Click here to add this to my saved trials
4-Day-A-Week Treatment Plan for HIV Infected Adolescents
Updated: 2/29/2016
Short-Cycle Therapy in Adolescents Following Continuous Therapy With Established Viral Suppression: The Impact on Viral Load Suppression
Status: Enrolling
Updated: 2/29/2016
4-Day-A-Week Treatment Plan for HIV Infected Adolescents
Updated: 2/29/2016
Short-Cycle Therapy in Adolescents Following Continuous Therapy With Established Viral Suppression: The Impact on Viral Load Suppression
Status: Enrolling
Updated: 2/29/2016
Click here to add this to my saved trials
4-Day-A-Week Treatment Plan for HIV Infected Adolescents
Updated: 2/29/2016
Short-Cycle Therapy in Adolescents Following Continuous Therapy With Established Viral Suppression: The Impact on Viral Load Suppression
Status: Enrolling
Updated: 2/29/2016
4-Day-A-Week Treatment Plan for HIV Infected Adolescents
Updated: 2/29/2016
Short-Cycle Therapy in Adolescents Following Continuous Therapy With Established Viral Suppression: The Impact on Viral Load Suppression
Status: Enrolling
Updated: 2/29/2016
Click here to add this to my saved trials
4-Day-A-Week Treatment Plan for HIV Infected Adolescents
Updated: 2/29/2016
Short-Cycle Therapy in Adolescents Following Continuous Therapy With Established Viral Suppression: The Impact on Viral Load Suppression
Status: Enrolling
Updated: 2/29/2016
4-Day-A-Week Treatment Plan for HIV Infected Adolescents
Updated: 2/29/2016
Short-Cycle Therapy in Adolescents Following Continuous Therapy With Established Viral Suppression: The Impact on Viral Load Suppression
Status: Enrolling
Updated: 2/29/2016
Click here to add this to my saved trials
A Novel Method to Determine HIV Incidence Among Youth
Updated: 2/29/2016
A Novel Method to Determine HIV Incidence Among Youth
Status: Enrolling
Updated: 2/29/2016
A Novel Method to Determine HIV Incidence Among Youth
Updated: 2/29/2016
A Novel Method to Determine HIV Incidence Among Youth
Status: Enrolling
Updated: 2/29/2016
Click here to add this to my saved trials
A Novel Method to Determine HIV Incidence Among Youth
Updated: 2/29/2016
A Novel Method to Determine HIV Incidence Among Youth
Status: Enrolling
Updated: 2/29/2016
A Novel Method to Determine HIV Incidence Among Youth
Updated: 2/29/2016
A Novel Method to Determine HIV Incidence Among Youth
Status: Enrolling
Updated: 2/29/2016
Click here to add this to my saved trials
A Novel Method to Determine HIV Incidence Among Youth
Updated: 2/29/2016
A Novel Method to Determine HIV Incidence Among Youth
Status: Enrolling
Updated: 2/29/2016
A Novel Method to Determine HIV Incidence Among Youth
Updated: 2/29/2016
A Novel Method to Determine HIV Incidence Among Youth
Status: Enrolling
Updated: 2/29/2016
Click here to add this to my saved trials
A Novel Method to Determine HIV Incidence Among Youth
Updated: 2/29/2016
A Novel Method to Determine HIV Incidence Among Youth
Status: Enrolling
Updated: 2/29/2016
A Novel Method to Determine HIV Incidence Among Youth
Updated: 2/29/2016
A Novel Method to Determine HIV Incidence Among Youth
Status: Enrolling
Updated: 2/29/2016
Click here to add this to my saved trials
A Novel Method to Determine HIV Incidence Among Youth
Updated: 2/29/2016
A Novel Method to Determine HIV Incidence Among Youth
Status: Enrolling
Updated: 2/29/2016
A Novel Method to Determine HIV Incidence Among Youth
Updated: 2/29/2016
A Novel Method to Determine HIV Incidence Among Youth
Status: Enrolling
Updated: 2/29/2016
Click here to add this to my saved trials
A Novel Method to Determine HIV Incidence Among Youth
Updated: 2/29/2016
A Novel Method to Determine HIV Incidence Among Youth
Status: Enrolling
Updated: 2/29/2016
A Novel Method to Determine HIV Incidence Among Youth
Updated: 2/29/2016
A Novel Method to Determine HIV Incidence Among Youth
Status: Enrolling
Updated: 2/29/2016
Click here to add this to my saved trials
A Novel Method to Determine HIV Incidence Among Youth
Updated: 2/29/2016
A Novel Method to Determine HIV Incidence Among Youth
Status: Enrolling
Updated: 2/29/2016
A Novel Method to Determine HIV Incidence Among Youth
Updated: 2/29/2016
A Novel Method to Determine HIV Incidence Among Youth
Status: Enrolling
Updated: 2/29/2016
Click here to add this to my saved trials
A Novel Method to Determine HIV Incidence Among Youth
Updated: 2/29/2016
A Novel Method to Determine HIV Incidence Among Youth
Status: Enrolling
Updated: 2/29/2016
A Novel Method to Determine HIV Incidence Among Youth
Updated: 2/29/2016
A Novel Method to Determine HIV Incidence Among Youth
Status: Enrolling
Updated: 2/29/2016
Click here to add this to my saved trials